Tamsulosin MR & Solifenacin Tablets Manufacturer in India & Exporter | Contract Manufacturing

Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablets

Categories : Nephrology & Urology

Product Packaging : 10 / 30 tablets

Product Composition : 0.4 mg & 6 mg

Tamsulosin Hydrochloride (MR) & Solifenacin Succinate Tablets are a specialized combination therapy developed for the management of benign prostatic hyperplasia (BPH) with co-existing overactive bladder (OAB) and lower urinary tract symptoms (LUTS). This dual-action formulation provides both bladder control and improved urinary flow:

Tamsulosin Hydrochloride (Modified Release) acts as a selective alpha-1A blocker, relaxing prostate and bladder neck muscles for smoother urine flow
Solifenacin Succinate is an antimuscarinic agent that reduces bladder overactivity, controlling urgency and frequency

Genliva Wellness LLP is a trusted Tamsulosin MR & Solifenacin Tablets manufacturer in India, offering premium-quality formulations through WHO-GMP and ISO-certified pharmaceutical manufacturing facilities. As a reliable exporter and contract manufacturer, the company ensures consistent quality, regulatory compliance, and global market acceptance.

With strong expertise in pharmaceutical contract manufacturing, third-party production, and global export, Genliva Wellness LLP supplies this combination to Africa, Southeast Asia, CIS countries, Middle East, and Latin America, supporting urology specialists, hospitals, and international pharmaceutical distributors.

Send Message

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Tamsulosin Hydrochloride (Modified Release) acts as a selective alpha-1A blocker, relaxing prostate and bladder neck muscles for smoother urine flow
Solifenacin Succinate is an antimuscarinic agent that reduces bladder overactivity, controlling urgency and frequency

Leading Tamsulosin Hydrochloride MR & Solifenacin Succinate Tablets manufacturer in India
Reliable Tamsulosin Solifenacin Tablets exporter for global pharmaceutical markets
Specialized Tamsulosin MR Solifenacin Tablets contract manufacturer for third-party production
Modified-release formulation for controlled and sustained drug delivery
Dual-action therapy targeting BPH, LUTS, and overactive bladder (OAB)
Tamsulosin MR ensures improved urinary flow and reduced obstruction
Solifenacin provides effective control over urinary urgency and frequency
Available in combinations such as Tamsulosin 0.4 mg MR + Solifenacin 5 mg tablets
Manufactured using high-quality APIs under strict quality assurance systems
Suitable for bulk supply, institutional procurement, and chronic therapy markets
Offered with custom packaging, private labeling, and export documentation support
Backed by Genliva’s reputation as a global pharmaceutical exporter from India

Tamsulosin MR & Solifenacin Tablets are widely used in urology for:

Treatment of benign prostatic hyperplasia (BPH)
Management of lower urinary tract symptoms (LUTS)
Control of overactive bladder (OAB) symptoms such as:
- Urinary urgency
- Increased frequency
- Urge incontinence
Improvement of urinary flow and bladder emptying
Reduction of bladder spasms and discomfort
Enhancement of patient quality of life in combined BPH + OAB conditions

Modified-release tablet ensures sustained and controlled drug release
Enables once-daily dosing for improved patient compliance
Combination therapy reduces need for multiple medications
Maintains stable plasma drug levels for better tolerability
High stability suitable for global export and long shelf life
Available in blister packs and bulk export packaging formats
Ideal for private label pharmaceutical brands and international distributors